Vol. 37 No. 2 (2022): The Archives of Rheumatology

Published: 2022-06-30

Full Issue

Cover & Table of Contents

Original Article

Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial

Laëtitia Michou, Anne-Laure Chetaille, Louis Bessette, Isabelle Fortin, Jean-Luc Tremblay, Judith Trudeau, Alena Ikic, Rebecca Lui, Geneviève Boily, Suzanne Côté, Johanne Tardif, Alexandra Godbout, Lucie Ratelle, Jean Légaré, Holly O. Witteman, Anne-Sophie Julien, Paul R Fortin

(169-179)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8965
PDF Abstract HTML Abstract

Serum and Synovial Fluid Levels of Interleukin-17A in Primary Knee Osteoarthritis Patients: Correlations With Functional Status, Pain, and Disease Severity

Shereen KAMEL, Rehab KHALAF, Hend MONESS, Shimaa AHMED

(187-194)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.7931
PDF Abstract HTML Abstract

Clinical and laboratory characteristics of chronic spontaneous urticaria with connective tissue diseases: A cross-sectional study

Songül Çildağ, Gökhan Sargın, Taşkın Şentürk

(205-211)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8784
PDF Abstract HTML Abstract

Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study

Emine Müge Acar, Senem Şaş, Fatmanur Aybala Koçak

(223-229)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8645
PDF Abstract HTML Abstract

The role of albumin-to-globulin ratio in undifferentiated arthritis: Rheumatoid arthritis versus primary Sjögren syndrome

Reyhan Köse Çobanoglu, Taşkın Şentürk

(245-251)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8742
PDF Abstract HTML Abstract

Serum lysyl oxidase concentration increases in long-standing systemic sclerosis: Can lysyl oxidase change over time?

Mohammad Hassan Jokar, Simin Jafaripour, Nafiseh Abdollahi, Maryam Nazemipour, Maliheh Moradzadeh, Mohammad Ali Mansournia

(261-270)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8977
PDF Abstract HTML Abstract

Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

(280-287)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8888
PDF Abstract HTML Abstract

The comparison of effects of balneotherapy, water-based and land-based exercises on disease activity, symptoms, sleep quality, quality of life and serum sclerostin level in patients with ankylosing spondylitis: A prospective, randomized study

Ersin Bestaş, Ümit Dündar, Tülay Köken, Buğra Koca, Hilal Yeşil

(159-168)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.9024
PDF Abstract HTML Abstract

Coronaphobia in patients with fibromyalgia

Sevinç Külekçioğlu, Merve Akyüz, Özenç İnan, Alp Çetin

(180-186)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8664
PDF Abstract HTML Abstract

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

(195-204)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8252
PDF Abstract HTML Abstract

Antioxidant glutathione inhibits inflammation in synovial fibroblasts via PTEN/PI3K/AKT pathway: An in vitro study

Wen Ting Hao, Lu Huang, Wei Pan, Yi Le Ren

(212-222)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.9109
PDF Abstract HTML Abstract

Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease?

Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour

(230-244)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.9086
PDF Abstract HTML Abstract

Thrombocytopenia in a cohort of primary and secondary antiphospholipid syndrome patients: Relation to clinical, laboratory manifestations and damage index

Sherif Gamal, Samar Mohamed, Abdelkawy Moghazy

(252-260)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.9088
PDF Abstract HTML Abstract

Association between clinical characteristics and pain relief in patients with axial spondyloarthritis treated with non-steroidal anti-inflammatory drugs

Shiyi Deng, Yi He, Sisi Deng, Erwei Sun, Li Li

(271-279)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8485
PDF Abstract HTML Abstract

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

(288-299)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8996
PDF Abstract HTML Abstract

Review

Vasculitis induced by biological agents used in rheumatology practice: A systematic review

Camila da Silva Cendon Duran, Adriane Souza da Paz, Mittermayer Barreto Santiago

(300-310)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.9049
PDF Abstract HTML Abstract

Letter to the Editor

A case of lupus erythematosus profundus with severe ulceration that responded to tumor necrosis factor-alpha--blocking agents

Daiki Nakagomi

(313-314)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.8908
PDF Abstract HTML Abstract

Fibrillarin antibodies in systemic sclerosis

Adrian Lee

(311-312)

DOI: https://doi.org/10.46497/ArchRheumatol.2022.9038
PDF Abstract HTML Abstract